跳至主要内容
临床试验/JPRN-UMIN000023343
JPRN-UMIN000023343已完成未知

Clinical study on the efficacy and safety of cultured (human) autologous hair follicle dermal sheath cup cells (DSCC) on androgenetic alopecia. - Clinical research study of autologous DSCC

Tokyo Medical University Hospital0 个研究点目标入组 67 人开始时间: 2016年7月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
67

研究概览

简要总结

Fifty men and 15 women aged 33 to 64 years were injected with DSC cells. Total hair density and cumulative hair diameter at the 300,000 DSC cells injection site was significantly increased compared with the placebo after 6 and 9 months. Men and women showed similar improvements, and there were no serious adverse events.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • The presence of any of the following will exclude a subject from study enrolment: 1. Use of any product (medication or otherwise) which interferes with the hair growth cycle. 2. Any systemic medical treatment for hair loss within the last 3 months. 3. Start of contraception treatments of oral contraceptives within the last 3 months. 4. Women who are pregnant or nursing and wish to get pregnant in clinical study period. 5. Presence of any medical condition that influences the hair growth cycle. 6. Infection has been confirmed by virological examination and syphilis testing carried out at the time of the screening. 7. Subjects diagnosed with cancer with or without chemotherapy treatment. 8. Sudden hair loss within the last 3 months unrelated to normal seasonal hair shedding or androgenetic alopecia. 9. Subjects in the process of or having completed surgical correction of hair loss in the past 24 months. 10. History of hypersensitivity has been confirmed by application of local anesthetic. 11. A lot of gray hair of the test areas (areas to be injected). 12 Investigator or the sharing researcher has determined to be inappropriate as a target.

研究者

相似试验